These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 39527305)

  • 21. Transforming vaccinology.
    Rappuoli R; Alter G; Pulendran B
    Cell; 2024 Sep; 187(19):5171-5194. PubMed ID: 39303685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. India's Potential as a Leader in Cancer Care Progress in the Future: A Synthetic Interdisciplinary Perspective.
    Singh A; Velu U; Lewis S; Nittala R; Yang J; Vijayakumar S
    Cureus; 2024 Oct; 16(10):e70892. PubMed ID: 39376975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Revolutionizing Cancer Treatment: Unleashing the Power of Viral Vaccines, Monoclonal Antibodies, and Proteolysis-Targeting Chimeras in the New Era of Immunotherapy.
    Mohite P; Yadav V; Pandhare R; Maitra S; Saleh FM; Saleem RM; Al-Malky HS; Kumarasamy V; Subramaniyan V; Abdel-Daim MM; Uti DE
    ACS Omega; 2024 Feb; 9(7):7277-7295. PubMed ID: 38405458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoinformatics assisted profiling of West Nile virus proteome to determine immunodominant epitopes for the development of next-generation multi-peptide vaccine.
    Karkashan A
    Front Immunol; 2024; 15():1395870. PubMed ID: 38799422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and development of mRNA and self-amplifying mRNA vaccine nanoformulations.
    Omidi Y; Pourseif MM; Ansari RA; Barar J
    Nanomedicine (Lond); 2024 Nov; ():1-27. PubMed ID: 39535127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ontology-based Precision Vaccinology for Deep Mechanism Understanding and Precision Vaccine Development.
    Xie J; Zi W; Li Z; He Y
    Curr Pharm Des; 2021; 27(7):900-910. PubMed ID: 33238868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restoring Trust: The Need for Precision Medicine in Infectious Diseases, Public Health and Vaccines.
    Equils O; Bakaj A; Wilson-Mifsud B; Chatterjee A
    Hum Vaccin Immunother; 2023 Aug; 19(2):2234787. PubMed ID: 37465958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advancements in monkeypox vaccines development: a critical review of emerging technologies.
    Garcia-Atutxa I; Mondragon-Teran P; Huerta-Saquero A; Villanueva-Flores F
    Front Immunol; 2024; 15():1456060. PubMed ID: 39464881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reverse engineering protection: A comprehensive survey of reverse vaccinology-based vaccines targeting viral pathogens.
    Ponne S; Kumar R; Vanmathi SM; Brilhante RSN; Kumar CR
    Vaccine; 2024 Apr; 42(10):2503-2518. PubMed ID: 38523003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. mRNA vaccine development and applications: A special focus on tumors (Review).
    Chen B; Yang Y; Wang X; Yang W; Lu Y; Wang D; Zhuo E; Tang Y; Su J; Tang G; Shao S; Gu K
    Int J Oncol; 2024 Aug; 65(2):. PubMed ID: 38994758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Personalized mRNA vaccines in glioblastoma therapy: from rational design to clinical trials.
    Karimi-Sani I; Molavi Z; Naderi S; Mirmajidi SH; Zare I; Naeimzadeh Y; Mansouri A; Tajbakhsh A; Savardashtaki A; Sahebkar A
    J Nanobiotechnology; 2024 Oct; 22(1):601. PubMed ID: 39367418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular engineering tools for the development of vaccines against infectious diseases: current status and future directions.
    Xue W; Li T; Gu Y; Li S; Xia N
    Expert Rev Vaccines; 2023; 22(1):563-578. PubMed ID: 37339445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel vaccine design based on genomics data analysis: A review.
    Lu G; Shan S; Zainab B; Ayaz Z; He J; Xie Z; Rashid U; Zhang D; Mehmood Abbasi A
    Scand J Immunol; 2021 Mar; 93(3):e12986. PubMed ID: 33043473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rational design of a multivalent vaccine targeting arthropod-borne viruses using reverse vaccinology strategies.
    Dhanushkumar T; Selvam PK; M E S; Vasudevan K; C GPD; Zayed H; Kamaraj B
    Int J Biol Macromol; 2024 Feb; 258(Pt 1):128753. PubMed ID: 38104690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Towards Precision Vaccines: Lessons From the Second International Precision Vaccines Conference.
    Soni D; Van Haren SD; Idoko OT; Evans JT; Diray-Arce J; Dowling DJ; Levy O
    Front Immunol; 2020; 11():590373. PubMed ID: 33178222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is there still hope for the prophylactic hepatitis C vaccine? A review of different approaches.
    Rzymski P; Jibril AT; Rahmah L; Abarikwu SO; Hashem F; Lawati AA; Morrison FMM; Marquez LP; Mohamed K; Khan A; Mushtaq S; Minakova K; Poniedziałek B; Zarębska-Michaluk D; Flisiak R
    J Med Virol; 2024 Sep; 96(9):e29900. PubMed ID: 39234788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospects and Challenges in Developing mRNA Vaccines for Infectious Diseases and Oncogenic Viruses.
    Kutikuppala LVS; Kourampi I; Kanagala RSD; Bhattacharjee P; Boppana SH
    Med Sci (Basel); 2024 May; 12(2):. PubMed ID: 38804384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computer Aided Reverse Vaccinology: A Game-changer Approach for Vaccine Development.
    Srivastava P; Jain CK
    Comb Chem High Throughput Screen; 2023; 26(10):1813-1821. PubMed ID: 36200250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. mRNA vaccines for infectious diseases - advances, challenges and opportunities.
    Pardi N; Krammer F
    Nat Rev Drug Discov; 2024 Nov; 23(11):838-861. PubMed ID: 39367276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.